Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterNo recent work listed

Ashley H. Davis-Yadley

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5020252607. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2015: 3 papers · 2016: 2 papers

Papers 5

  1. Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000580↗
  2. Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic Cancer. First author DOI 10.1097/rlu.0000000000001098↗
  3. Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000218↗
  4. Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma. First author DOI 10.1371/journal.pone.0133562↗
  5. Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications. Co-author DOI 10.3945/an.115.009456↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mokenge Peter Malafa · 5 shared papers, 2015–2016 · strength 0.35
  2. Dung‐Tsa Chen · 4 shared papers, 2015–2016 · strength 0.24
  3. José M. Pimiento · 4 shared papers, 2015–2016 · strength 0.24
  4. Kazim M. Husain · 2 shared papers, 2015 · strength 0.10
  5. Barbara Ann Centeno · 2 shared papers, 2015 · strength 0.10
  6. Richard D. Kim · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.